- Home
- RLAY vs RSI Comparison
RLAY vs RSI Comparison
Compare RLAY & RSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLAY | RSI |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.9B |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | RLAY | RSI |
|---|---|---|
| Price | $13.50 | $27.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 10 |
| Target Price | $19.50 | ★ $28.20 |
| AVG Volume (30 Days) | ★ 3.8M | 2.1M |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 31.78 | ★ 933.33 |
| EPS | N/A | ★ 0.08 |
| Revenue | $15,355,000.00 | ★ $1,134,428,000.00 |
| Revenue This Year | N/A | $25.44 |
| Revenue Next Year | $324.03 | $14.27 |
| P/E Ratio | ★ N/A | $339.69 |
| Revenue Growth | ★ 53.44 | 22.76 |
| 52 Week Low | $2.83 | $11.76 |
| 52 Week High | $17.32 | $29.24 |
Technical Indicators
Market Signals| Indicator | RLAY | RSI |
|---|---|---|
| Relative Strength Index (RSI) | 54.25 | 58.24 |
| Support Level | $11.75 | $26.00 |
| Resistance Level | $17.32 | $29.24 |
| Average True Range (ATR) | 0.94 | 1.04 |
| MACD | 0.01 | -0.24 |
| Stochastic Oscillator | 49.61 | 42.35 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
About RSI Rush Street Interactive Inc.
Rush Street Interactive Inc is an online gaming and entertainment company that focuses on online casinos and online sports betting in the U.S. and Latin American markets. It provides customers with an array of gaming offerings such as real-money online casinos, online sports betting, and retail sports betting, as well as social gaming, which involves free-to-play games that use virtual credits that can be earned or purchased. The company generates revenue by offering online casinos, online sports betting, and social gaming directly to the end customer through its websites or apps. The company generates revenue through business-to-consumer (B2C) and business-to-business (B2B) models.